Abstract
This article reviews past and current studies of hepacellular carcinoma (HCC), current investigations, the direction of research on HCC, and future perspectives. The discussion is based mainly on a survey of the literature and the author's experiences with patients. Capability for diagnosing premalignant lesions is very limited, and methods are needed to predict the nature of hepatic nodules and diagnose early HCC. Current practice is far from satisfactory. Diagnosis of early HCC should not depend on H&E staining alone. More molecular information should be obtained for diagnosing early lesions. Prevention is the only way to reduce the number of HCC patients. There are four steps for prevention which require further attention and improvement.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
